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ABSTRACT 
Objective: The present study aimed to improve the rate of dissolution of furosemide by solid dispersion technique.  
Methods: Solid dispersion of furosemide was prepared by using hydrogel isolated from the seeds of Lepidium sativum as a novel carrier by the 
solvent evaporation method. Solid dispersion was evaluated to study the improvement in the rate of dissolution. Molecular dispersion of furosemide 
in the novel carrier was studied by DSC and FTIR studies. Solid dispersion was filled in capsules after stability studies and the formulation was 
optimized by adopting factorial design.  
Results: Solid dispersion of furosemide exhibited dissolution improvement from 13.54 % (plain furosemide) to 69.12% (solid dispersion) in the 
first 60 min. Improvement in dissolution efficiency was found to be retained after stability studies. Capsules were filled with the formulation of solid 
dispersion using two different grades of lactose-α lactose monohydrate and anhydrous lactose and were found stable after stabilization studies.  
Conclusion: The dissolution improvement of furosemide was attributed to its molecular dispersion in the novel carrier selected for this study. The 
recrystallization of furosemide was prevented due to intermolecular interaction between the novel carrier and furosemide. This was confirmed by 
FTIR. Evaluation of the dissolution data of factorial batches was analyzed by ANOVA. Analysis of the data revealed that selected levels of α lactose 
monohydrate and anhydrous lactose would be useful to navigate design space. 
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INTRODUCTION 
Furosemide is a BCS class IV drug and is a weakly acidic loop 
diuretic used for oral treatment of edema and hypertension. It 
shows the variable rate and extent of absorption resulting in poor 
oral bioavailability (37%–51%). It is a substrate for the P-gp efflux 
system expressed in lower GIT and hence it is poorly permeable. 
Since poor permeability of furosemide is due to its efflux in the 
lower small intestine; enabling dissolution of furosemide to the 
extent to ensure its adequate absorption through upper GIT is 
sufficient to improve its bioavailability [1, 2]. Solid dispersion is a 
widely adopted formulation approach to enable dissolution because 
of its feasibility, reproducibility, and ease of optimization. Molecular 
dispersion of furosemide in a selected novel carrier was prepared in 
the present study. It is reported that if water-soluble carriers ate 
preferred; the incidence of recrystallization of a molecularly 
dispersed drug is reduced. Therefore molecular dispersion of 
furosemide was prepared with hydrogel isolated from the seeds of 
Lepidium sativum as a novel hydrophilic carrier [3, 4]. In an attempt 
to improve the dissolution of a drug through its molecular 
dispersion in a hydrophilic carrier; the recrystallization of a drug 
during storage is a point of major concern. This problem can be 
mitigated by proper polymer selection. Suitable material that is 
capable of interacting with drug molecules through hydrogen 
bonding is expected to prevent the recrystallization. The hydrogel 
was isolated from the seeds of Lepidium sativum (gel) and used in 
this study as novel material as it was studied as a disintegrating 
agent and reported by Patel et al.; 2011 [5-8]. 
The stability of molecular dispersion of furosemide was confirmed 
and its formulation to be filled in capsules was developed and 
optimized by adopting factorial design. Lactose is routinely used 
diluent/filler in capsule dosage forms. Crystalline α-lactose 
monohydrate and crystalline anhydrous lactose are the most 
frequently used forms of lactose in the pharmaceutical industry. The 
present work aimed to improve the dissolution of furosemide. 
Hence, the influence of lactose as one of the major components of 
the formulation; on the dissolution efficiency of molecularly 
dispersed furosemide was necessary to be assessed. The grade of 
lactose was selected as one variable factor and amount of silicon 
dioxide as the second variable factor. Silicon dioxide is a 
hydrophobic lubricant; the study of its effect on the dissolution of 
furosemide was required [9, 10]. Design Expert (Demo version 11-
Stat-Ease, Inc, USA) was used for the analysis of the effect of each 
variable on the designated response i.e. dissolution efficiency. The 
analysis of data suggested that the selected levels of factors (two 
grades of lactose and the amount of silicon dioxide) can be used to 
navigate the design space [11]. 
MATERIALS AND METHODS  
Materials  
Furosemide was obtained as a gift sample from Cipla Ltd., 
Kurkhumbh, India. Seeds of Lepidium sativum were purchased from 
a local source and were authenticated CSIR-National Botanical 
Institute (authentication number-LWG-46) and deposited in 
National Repository, Lucknow, India. All other chemicals used in the 
analysis were of analytical grade and others were at least of 
pharmaceutical grade and used without further purification. 
Methods  
Isolation of hydrogel from the seeds of Lepidium sativum 
The hydrogel was isolated from whole seeds of Lepidium Sativum by 
soaking them in demineralized water. The entire bulk was 
homogenized and passed through a muslin cloth to obtain the gel. 
FTIR of hydrogel obtained from the seeds of Lepidium sativum 
The gel was isolated from the seeds of Lepidium Sativum, and dried 
in hot air oven (at 80 °C for sufficient time to remove the water 
completely) and taken for FTIR analysis. Powder of potassium 
bromide (KBr) was heated for 1.5 h. to remove moisture at 160 °C. 
Dried Gel was mixed thoroughly with KBr in the proportion of 1:1. 
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The FTIR spectrum was recorded using a JASCO FTIR instrument. 
The result was obtained in the form of a graph of % Transmittance 
vs. Wave no. Then the mixture was scanned over the 400-4000 cm-1. 
Preparation of solid dispersion of furosemide 
Gel (mucilage) isolated from the seeds of Lepidium sativum was used 
in the preparation of solid dispersion of Furosemide. Solid dispersion 
of Furosemide was prepared by adopting the solvent evaporation 
method [12]. Furosemide was dissolved in ethanol (50 ml). Sufficient 
amount of gel was mixed with an ethanolic solution of furosemide in to 
attain 1:1, 1:2 and 1:3 proportions by weight of furosemide and dried 
Gel. The mixture was homogenized for 30 min and then was dried in 
an oven for 50 min at 80 °C. These solid dispersions were 
characterized and evaluated for dissolution studies.  
Characterization and evaluation of solid dispersion of 
furosemide 
Uniformity of content of furosemide in solid dispersion 
The sufficient amount of solid dispersion equivalent to 40 mg of 
furosemide was weighed accurately. The actual amount of 
furosemide present in solid dispersion was determined by 
dissolving it in 50 ml of dimethyl-formamide to which has been 
added 3 drops of Bromothymol blue T. S. which previously has been 
neutralized 0.1 N NaOH; titrated with 0.1N NaOH [13].  
FTIR analysis of solid dispersion 
FTIR of solid dispersion recorded to study molecular interaction 
between furosemide and gel. Potassium bromide (KBr) was heated 
for 1.5 hr. at 160 ° C to remove moisture. Solid dispersion was mixed 
thoroughly with KBr in the proportion of 1:1. The FTIR spectrum of 
the solid dispersion was recorded using a JASCO FTIR instrument. 
The result was obtained in the form of a graph of % Transmittance 
vs. Wave no. Then the mixture was scanned over the 400-4000 cm-1. 
Determination of dissolution efficiency of solid dispersion of 
furosemide  
Solid dispersion equivalent to the 40 mg of furosemide was weighed 
accurately and put in the vessel of the USP II dissolution apparatus 
containing 900 ml of phosphate buffer pH 5.8. The dissolution 
medium was maintained at 37 °C±0.5 °C. The speed of the rotating 
shaft was 50 rpm. The aliquots of 5 ml were withdrawn at 
predetermined time intervals, filtered and diluted sufficiently. The 
absorption was measured at 277 nm and the cumulative amount 
dissolved was calculated. The dissolution efficiency (D. E.) of solid 
dispersion is the area under the dissolution curve of the rectangle 
described by 100% dissolution in the same time [14]. It was 
calculated by the following equation- 
D. E. =
 0∫ ty × dt 
y100 × t
× 100------------------Eq. n 1 
Where ‘y’ is the drug percent dissolved at the time ‘t’. 
Stability study 
Stability studies were conducted for the solid dispersion of Drug: Gel 
in 1:3 proportions to confirm the dissolution improvement even 
after the stability period. Solid dispersion was packed in aluminum 
foil and exposed to 40˚C/75% RH for two months according to the 
guidelines from the International Council for Harmonization (ICH) 
[15]. Solid dispersion was evaluated for the parameters as 
uniformity of content, dissolution efficiency and DSC. 
Optimization of the capsule as a dosage form by factorial design 
Bulk formulations of solid dispersion were prepared by mixing the 
appropriate quantity of solid dispersion with 62.5% lactose (α 
monohydrate and anhydrous) as a filler/diluent and silicon dioxide 
1.5% as a glidant for 10 min. A 22full factorial design was used for 
the optimization of the composition of the bulk of solid dispersion to 
be filled in capsules [16, 17]. According to the model it contained 2 
independent variables at 2 levels,+1,-1. According to the model, the 
total four formulations are possible, the composition of the different 
formulation is shown in table 1. The different independent variables 
were α lactose monohydrate or anhydrous lactose (X1) and the 
amount of colloidal silicon dioxide (X2). The factor levels were chosen 
to their relative alteration was acceptable to have powder bulk with 
flow property (i.e. if the angle of repose was between 28 to 34) and 
compressibility (i.e. Hausner’s ratio between 1.12 to 1.2). The 
dependent factor included dissolution efficiency at 60 min after 
stability studies. Stability studies of all the factorial formulations 
were conducted. All formulations were exposed to 40˚C/75% RH for 
three months according to the guidelines from the International 
Council for Harmonization (ICH) and were evaluated for dissolution 
studies. Design Expert (Demo version 11-Stat-Ease, Inc, USA) was 
used for the analysis of the effect of each variable on the designated 
response i.e. dissolution efficiency. The significant response 
polynomial equations generated by Design Expert were used to 
validate the statistical design. Response surface plots were 
generated to visualize the simultaneous effect of each variable on 
each response parameter. The constant and regression coefficients 
were also calculated using the software. 
 
Table 1: Composition of powder blend for preparation of factorial batches 
 Ingredients (mg/capsule) 
formulation code 
FRU SD equivalent  
to 40 mg of CLA 
Lactose* Colloidal silicon dioxide Total weight of the tablet 
F1 (-,-) 160 100 4 264 
F2 (+,-) 160 100 4 264 
F3 (-,+) 160 100 8 268 
F4 (+,+) 160 100 8 268 
* F1 and F3 were prepared by using α lactose monohydrate and F2 and F4 were prepared by using anhydrous lactose. 
 
Table 2: Translation of coded value in actual unit 
 Variable level − + 
X1= Grade of lactose  α lactose monohydrate  Anhydrous lactose 
X2 = Colloidal silicon oxide 04 mg 08 mg 
 
RESULTS AND DISCUSSION 
Isolation of hydrogel from the seeds of lepidium sativum 
The hydrogel was isolated from whole seeds of Lepidium Sativum 
and the appearance of the gel was translucent and brownish. The 
specific gravity of the gel was found to be 1.009 and was comparable 
to water revealing very high water uptake by the gel-forming 
material.  
FTIR of hydrogel obtained from the seeds of Lepidium sativum 
The composition of Gel is reported in the literature. It contains 
arabinose, xylose and rhamnose and the highest amount of uronic 
acid (galacturonic acid+glucuronic acid). FTIR spectrum of the dried 
is shown in fig. 1. The spectra exhibited all typical bands and peaks 
characteristic of polysaccharides. The major identical peaks are 
similar and in good agreement with those reported for Lepidium 
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sativum seed mucilage. A band around 2921 cm-1 (3000-2800 cm-1) 
referred to C-H vibrations, which included CH, CH2 and CH3 
stretching and bending vibrations, symmetric, and asymmetric and 
occasionally doubles overlapping with O-H. The characteristic bands 
around 1668 cm-1 and 1463 cm-1 were attributed to the 
asymmetrical and the symmetrical COO-stretching vibrations, 
respectively. The peak at 1066 cm-1 indicated the presence of 
carbohydrates [18, 19]. 
 
 
Fig. 1: FTIR spectrum of dried mucilage of Lepidium sativum 
 
Preparation of solid dispersion of furosemide 
Uniformity of content of furosemide in solid dispersion 
Solid dispersion was prepared in three lots and was faint brown in 
appearance. The yield was calculated and it was found to be more 
than 95%. The uniformity of the content of furosemide in its solid 
dispersion form was found to be 96.12%±1.74. Further calculations 
were done with necessary corrections accordingly. 
FTIR analysis of solid dispersion 
FTIR spectra of plain furosemide (fig. 2) and its solid dispersion (fig. 
3) were compared and revealed hydrogen bonding between them. 
The characteristic peak of the primary amine (NH2) group that was 
observed at 1568 cm-1 in FTIR of plain furosemide was downshifted 
at1430 cm-1 in FTIR of solid dispersion of furosemide. Similarly, the 
characteristic peak of the ketone carbonyl group that was observed 
at 1678 cm-1 in FTIR of plain furosemide was downshifted at1611 
cm-1 in FTIR of solid dispersion of furosemide. The broadening of the 
absorption band in the OH stretching region also indicated 
intermolecular hydrogen bonding [20, 21]. 
Determination of dissolution efficiency of solid dispersion of 
furosemide  
In an attempt to design a scalable manufacturing method of solid 
dispersion, the amount of carrier needed to achieve the desired 
improvement in dissolution characteristics of the drug is a major 
factor. The gel was selected as a novel carrier in the present 
study. Hence, the solid dispersion of Drug: Gel was prepared by 
using gel in increasing proportions and its influence on 
dissolution characteristics of the furosemide was carefully 
studied. As the proportion of gel was increased in the 
preparation of solid dispersion, dissolution was found to be 
gradually increased. There was an increase in the dissolution 
efficiency of furosemide in its solid dispersion form (in 
proportion 1:3) when compared to that with plain furosemide as 
from 13.54% to 69.12% in first 60 min (table 3 and fig. 4). This 
improvement was statistically significant [22]. This might be due 
to the well-reported wetting effect of the hydrophilic gel that is 
used as a novel carrier in the present study and molecular 
dispersion of the furosemide in the carrier system [23]. 
  
 
Fig. 2: FTIR spectrum of furosemide 
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Fig. 3: FTIR spectrum of solid dispersion of furosemide 
 
Table 3: Percent cumulative dissolution data for SD of furosemide and plain furosemide 
Time  
(min) 
Plain furosemide % Cumulative dissolution for solid dispersions of various proportions of the drug: gel* 
1:1 1:2 1:3 
00 00 00 00 00 
05 5.88±0.19 29.55±0.29 25.85±0.12 40.17±0.11 
10 8.61±0.31 32±0.23 36.83±0.21 54.77±0.23 
15 11.01±0.11 33.38±0.12 49.9±0.25 60.83±0.06 
20 13.5±0.23 38.94±0.12 62.14±0.13 63.40±0.20 
25 14.86±0.49 39.77±0.15 66.47±0.32 68.22±0.10 
30 15.16±0.17 40.33±0.22 66.13±0.08 74.35±0.30 
45 16.19±0.33 40.55±0.20 71.19±0.12 84.38±0.21 
60 18.55±1.6 43.33±0.18 75.65±0.23 93.55±0.21 
*All values indicate mean±SD (n=3) 
 
 
Fig. 4: Percent cumulative drug release of different furosemide: gel ratio’s 
 
Stability study 
In the overall developments in amorphous solid dispersions, re-
crystallization of the drug in solid dispersion form i.e. physical 
stability of the dispersion is a factor of serious concern. The strategy 
to stabilize the molecular dispersion/amorphous form of a drug in 
its solid dispersion demands interactions such as hydrogen bonding 
between the drug and hydrophilic polymer used in the solid 
dispersion [24]. FTIR study already revealed hydrogen bonding 
between furosemide and gel. Therefore stability studies were 
planned and conducted to confirm the stability of molecular 
dispersion/amorphous form of a drug in its solid dispersion. 
Uniformity of content of furosemide remained above 95% even 
when the solid dispersion was exposed to 40˚C/75%RH i.e. after 
stability testing studies for two months. Dissolution efficiency was 
found to be 68.33%. Differential Scanning calorimetry was 
performed to confirm the amorphous nature of the drug in solid 
dispersion. The DSC scans of furosemide in its solid dispersion 
recorded at the end of stability studies revealed that the drug 
exothermic characteristic peak (fig. 5) disappeared completely. This 
might be explained based on the homogeneous dispersion of 
furosemide in hydrophilic carrier i.e. gel [25]. Therefore it was 
concluded that the marked improvement in the dissolution of 
furosemide was due to molecular dispersion/amorphization of the 
furosemide in the hydrophilic gel. The recrystallization of 
furosemide was mitigated due to intermolecular hydrogen bonding 
between the furosemide and novel carrier selected in the present 
study. Solid dispersion of Furosemide: gel in 1:3 proportions was 
taken further to develop its suitable dosage form.  
Optimization of the capsule as a dosage form by factorial design 
Recrystallization of the amorphous form of a drug is promoted due 
to the application of the compression force [26]. Also, most of the 
formulations are filled into the capsules for the conduct of clinical 
trials. Therefore capsules as drug delivery systems were selected in 
the present study. The formulation to be filled in the capsules 
requires a specific flow and density profile. Lactose is a well-
accepted excipient, widely used as a diluent, filler-bulking agent in 
the capsule as a solid oral dosage form. It is available in various 
grades with different physical properties. Various grades of lactose 
are available and are routinely used in the bulk formulations to be 
filled in the capsules. The process demands a specific grade of 
lactose to make the bulk free-flowing to somewhat cohesive for a 
specific formulation. Two different grades of lactose-α lactose 
monohydrate or crystalline anhydrous lactose were selected as 
diluents to prepare the bulk of solid dispersion to be filled in 
capsules [27]. The levels of lactose were selected based on the 
evaluation of preliminary bulk formulations and the recommended 
amounts for BCS class IV compounds [28]. Preliminary bulk 
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formulations were prepared by mixing lactose of either grade in the 
proportion reported to be appropriate for BCS class IV API 
(furosemide). The bulk formulations that exhibited acceptable flow 
properties, as well as compressibility, were further selected for 
optimization of the formulation by adopting factorial design. Silicon 
dioxide was used as a glidant. Capsules were evaluated for contents 
of the active ingredient and were found 98.85% w/w. Three 
capsules from each factorial batch were taken for measurement of 
dissolution efficiency and the results are reported in table 4. 
The data obtained after evaluation of factorial batches were 
analyzed by using the demo version of commercially available 
software Design Expert (Version 11). To describe the response 
surface curvature (fig. 5), the design was evaluated by the quadratic 
model, which bears the form of the equation– 
D. E. Y = 68.34 + 0.45X1 − 0.02X2 − 0.01X1X2 −--------------Eq. n 2 
Anhydrous lactose exhibited faster dissolution than when lactose 
monohydrate was used; as indicated by the positive coefficient of X1. 
As the amount of silicon dioxide was increased in the formulation 
the dissolution rate slowed down; as indicated by the negative 
coefficient of X2. The high numerical value of the coefficient of X1 
indicated that the grade of lactose used in the formulation has more 
impact on dissolution than the amount of silicon dioxide added. The 
interaction between factor X1 and X2 was not considerable and both 
were found to negate the effect of each other to some extent. It was 
obvious by the negative coefficient of X1X2. 
Analysis of the evaluation data generated for dissolution efficiency 
by applying ANOVA suggested that the significant factors affecting 
dissolution efficiency were the grade of lactose and the amount of 
silicon dioxide. F value for silicon dioxide and the interaction term 
was at p ≥ 0.05 and suggested low confidence in the inference 
drawn. Thus, the effect of silicon dioxide on the dissolution 
efficiency of solid dispersion has to be planned with logical 
modifications to refine the results. Design space is applicable to scale 
up and to a site change and working within a design space is not 
considered as a change. As per ICH Q8 (R2) guidelines, the factorial 
design was adopted to establish design space. The fit statistics (table 
5) suggested that the selected levels of factors (two grades of lactose 
and the amount of silicon dioxide) can be used to navigate the design 
space.
  
Table 4: Dissolution efficiency (%) for factorial batches 
Formulation F1(−,−) F2(+,−)  F3(−,+) F4(+,+) 
D. E. (%) 67.90±0.32 68.82±0.26 68.16±0.26 68.87±0.21 
 
 
Fig. 5: Surface response curvatures 
 
Table 5: Analysis of data after applying anova 
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CONCLUSION 
Solid dispersion of furosemide was prepared by the solvent 
evaporation technique using hydrogel isolated from the seeds of 
Lepidium sativum (gel) as a novel carrier. Dissolution efficiency of 
solid dispersion of furosemide (Furosemide: Dried gel in 1:3 
proportions) was improved from 13.54 % (plain furosemide) to 
69.12% in the first 60 min. Molecular dispersion of furosemide in 
carrier (in its solid dispersion form) was found to be the major cause 
of its improved dissolution. Solid dispersion of furosemide was 
found to be stable and recrystallization was mitigated during 
stability studies. This was due to the selection of proper hydrophilic 
carrier and its inclusion in the solid dispersion in appropriate 
proportion. The stability of amorphous solid dispersion was found 
to be due to intermolecular interaction between furosemide and 
novel carrier through hydrogen bonding and confirmed by FTIR 
studies. Immediate-release capsule formulation of amorphous solid 
dispersion of furosemide was optimized by adopting factorial 
design. Data of dissolution efficiency of factorial batches was 
analyzed by ANOVA by using Design Expert (Demo Version 11) and 
results revealed that the levels of factors selected would be useful to 
navigate design space. 
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